<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>daVi DigitalMedicine srl - Le Fonti New Pharma Italy</title>
	<atom:link href="https://www.newpharmaitaly.it/tag/davi-digitalmedicine-srl/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.newpharmaitaly.it/tag/davi-digitalmedicine-srl/</link>
	<description>Il portale delle news in ambito farmaceutico</description>
	<lastBuildDate>Thu, 07 Mar 2024 16:44:04 +0000</lastBuildDate>
	<language>it-IT</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://www.newpharmaitaly.it/wp-content/uploads/2022/12/cropped-favicon-new-pharma-italy-32x32.jpg</url>
	<title>daVi DigitalMedicine srl - Le Fonti New Pharma Italy</title>
	<link>https://www.newpharmaitaly.it/tag/davi-digitalmedicine-srl/</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>QK-Digital per il trattamento della Ipertensione Arteriosa</title>
		<link>https://www.newpharmaitaly.it/qk-digital-per-il-trattamento-della-ipertensione-arteriosa/</link>
		
		<dc:creator><![CDATA[Elvis Kondi]]></dc:creator>
		<pubDate>Fri, 07 Oct 2022 15:41:19 +0000</pubDate>
				<category><![CDATA[Innovazione]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[Protagonisti]]></category>
		<category><![CDATA[daVi DigitalMedicine srl]]></category>
		<category><![CDATA[Digital Therapeutic]]></category>
		<category><![CDATA[ipertensione]]></category>
		<category><![CDATA[QK-Digital]]></category>
		<category><![CDATA[SIIA]]></category>
		<guid isPermaLink="false">https://www.newpharmaitaly.it/?p=48528</guid>

					<description><![CDATA[<p>QK-Digital, primo candidato italiano Digital Therapeutic per il trattamento della Ipertensione Arteriosa, presentato al Congresso Nazionale 2022 della SIIA - Società Italiana Ipertensione Arteriosa</p>
<p>L'articolo <a href="https://www.newpharmaitaly.it/qk-digital-per-il-trattamento-della-ipertensione-arteriosa/">QK-Digital per il trattamento della Ipertensione Arteriosa</a> proviene da <a href="https://www.newpharmaitaly.it">Le Fonti New Pharma Italy</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>Polifarma spa, daVinci Digital Therapeutics srl e daVi DigitalMedicine srl in partnership</title>
		<link>https://www.newpharmaitaly.it/polifarma-spa-davinci-digital-therapeutics-srl-e-davi-digitalmedicine-srl-in-partnership/</link>
		
		<dc:creator><![CDATA[Elvis Kondi]]></dc:creator>
		<pubDate>Fri, 21 Jan 2022 10:19:21 +0000</pubDate>
				<category><![CDATA[Interviste]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[Protagonisti]]></category>
		<category><![CDATA[daVi DigitalMedicine srl]]></category>
		<category><![CDATA[daVinci Digital Therapeutics srl]]></category>
		<category><![CDATA[Polifarma]]></category>
		<guid isPermaLink="false">https://www.newpharmaitaly.it/?p=44767</guid>

					<description><![CDATA[<p>Polifarma spa, daVinci Digital Therapeutics e daVi DigitalMedicine avviano la collaborazione per lo sviluppo e la commercializzazione di Digital Drug Supports e Digital Therapeutics per migliorare il trattamento delle malattie croniche.</p>
<p>L'articolo <a href="https://www.newpharmaitaly.it/polifarma-spa-davinci-digital-therapeutics-srl-e-davi-digitalmedicine-srl-in-partnership/">Polifarma spa, daVinci Digital Therapeutics srl e daVi DigitalMedicine srl in partnership</a> proviene da <a href="https://www.newpharmaitaly.it">Le Fonti New Pharma Italy</a>.</p>
]]></description>
		
		
		
			</item>
	</channel>
</rss>
